Serum Adiponectin Predicts COVID-19 Severity

被引:2
|
作者
Pavel, Vlad [1 ]
Raeth, Ulrich [1 ]
Schmid, Stephan [1 ]
Krautbauer, Sabrina [2 ]
Keller, Dennis [1 ]
Amend, Pablo [1 ]
Mueller, Martina [1 ]
Mester, Patricia [1 ]
Buechler, Christa [1 ]
机构
[1] Univ Hosp Regensburg, Dept Internal Med Gastroenterol Hepatol Endocrinol, D-93053 Regensburg, Germany
[2] Univ Hosp Regensburg, Inst Clin Chem & Lab Med, D-93053 Regensburg, Germany
关键词
adiponectin; disease severity; C-reactive protein; intensive care; bacterial superinfection; COVID-19; ADIPOSE-TISSUE; EXPRESSION; MORTALITY; MARKERS; OBESITY; SEPSIS;
D O I
10.3390/biomedicines12051043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Adiponectin is primarily known for its protective role in metabolic diseases, and it also possesses immunoregulatory properties. Elevated levels of adiponectin have been observed in various inflammatory diseases. However, studies investigating adiponectin levels in the serum of COVID-19 patients have yielded conflicting results. This study aimed to assess serum adiponectin levels in 26 healthy controls, as well as in 64 patients with moderate and 60 patients with severe COVID-19, to determine a potential association between serum adiponectin and the severity of COVID-19. Serum adiponectin levels in severe COVID-19 patients were significantly lower than in those with moderate disease and healthy controls, who exhibited similar serum adiponectin levels. Among patients with moderate disease, positive correlations were observed between serum adiponectin and C-reactive protein levels. Of note, serum adiponectin levels of severe COVID-19 cases were comparable between patients with and without dialysis or vasopressor therapy. Superinfection with bacteria did not exert a notable influence on serum adiponectin levels in patients with severe disease. Patients who were diagnosed with severe COVID-19 and vancomycin-resistant enterococci bacteremia showed a significant reduction in their serum adiponectin levels. An analysis conducted on the entire cohort, including both moderate and severe COVID-19 patients, showed that individuals who did not survive had lower serum adiponectin levels when compared to those who survived. In summary, this study highlights a decrease in serum adiponectin levels in severe COVID-19 cases, indicating the potential utility of adiponectin as an additional biomarker for monitoring disease severity in COVID-19 or critical illnesses in general.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] The Association of Serum Profile of Transferrin Isoforms with COVID-19 Disease Severity
    Chrostek, Lech
    Gan, Kacper
    Kazberuk, Marcin
    Kralisz, Michal
    Janicka, Katarzyna
    Gruszewska, Ewa
    Panasiuk, Anatol
    Cylwik, Bogdan
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [42] Use of convalescent serum reduces severity of COVID-19 in nonhuman primates
    Cross, Robert W.
    Prasad, Abhishek N.
    Borisevich, Viktoriya
    Woolsey, Courtney
    Agans, Krystle N.
    Deer, Daniel J.
    Dobias, Natalie S.
    Geisbert, Joan B.
    Fenton, Karla A.
    Geisbert, Thomas W.
    CELL REPORTS, 2021, 34 (10):
  • [43] Serum ferritin as an independent risk factor for severity in COVID-19 patients
    Lin, Zhi
    Long, Fei
    Yang, Yong
    Chen, Xiangyu
    Xu, Linyong
    Yang, Minghua
    JOURNAL OF INFECTION, 2020, 81 (04) : 670 - 672
  • [44] Role of Serum Amyloid A as a Biomarker for Predicting the Severity and Prognosis of COVID-19
    Abbas, Amal A.
    Alghamdi, Asma
    Mezghani, Sonia
    Ben Ayed, Mourad
    Alamori, Ahmed M.
    Alghamdi, Ghazi A.
    Bajhmom, Wail
    Wajeeh, Hanan
    Almutairi, Salma S.
    Radwan, Wafaa M.
    JOURNAL OF IMMUNOLOGY RESEARCH, 2022, 2022
  • [45] Serum levels of IGF system proteins change with the severity of COVID-19
    Garcia Pichel, J. M.
    Lopez, I. P.
    Villoslada, P.
    Iniguez, M.
    Recio-Fernandez, E.
    Hoflich, C.
    Hoeflich, A.
    Oteo, J. A.
    Perez-Matute, P.
    FEBS OPEN BIO, 2022, 12 : 157 - 158
  • [46] ASSOCIATION OF SERUM LIPID LEVELS WITH COVID-19 INFECTION, SEVERITY AND MORTALITY
    Chidambaram, V.
    Shanmugavel, H.
    Kumar, A.
    Voruganti, D.
    Mehta, J. L.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 458 - 458
  • [47] The predictive value of serum level of cystatin C for COVID-19 severity
    Luanfeng Lin
    Xiaoling Chen
    Junnian Chen
    Xiaobin Pan
    Pincang Xia
    Hailong Lin
    Houwei Du
    Scientific Reports, 11
  • [48] Relationship between serum osteopontin levels and the severity of COVID-19 infection
    Ceyhun Varım
    Taner Demirci
    Hasret Cengiz
    İlhan Hacıbekiroğlu
    Fatima Betul Tuncer
    Erdem Çokluk
    Hande Toptan
    Oguz Karabay
    İlhan Yıldırım
    Wiener klinische Wochenschrift, 2021, 133 : 298 - 302
  • [49] Polymorphisms and Severity of COVID-19
    Sookaromdee, Pathum
    Wiwanitkit, Viroj
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207 (01) : 112 - 112
  • [50] Assessing the severity of COVID-19
    Ribas Freitas, Andre Ricardo
    Napimoga, Marcelo
    Donalisio, Maria Rita
    EPIDEMIOLOGIA E SERVICOS DE SAUDE, 2020, 29 (02):